Dawn Mattoon Biography and Net Worth

VP of Quanterix

Dr. Dawn R. Mattoon Ph.D serves as Senior Vice President - Research Products of the Company. She has been our Senior Vice President, Research Products since March 2019 and served as Senior Vice President of Strategic Marketing and Assay Technologies from February 2018 to March 2019. Dr. Mattoon completed both her Ph.D. and postdoctoral work at Yale University, studying tyrosine kinase signaling pathways. Following her postdoctoral fellowship in 2004, she joined Invitrogen, where she was recognized as one of the company's best new scientists in 2005. Dr. Mattoon went on to serve in a variety of leadership roles in R&D, Program & Portfolio Management, Strategy, and General Management as Invitrogen evolved to become Life Technologies with the acquisition of Applied Biosystems in 2008, and was subsequently acquired by Thermo Fisher in 2013. Until her departure from Thermo Fisher in 2014, Dr. Mattoon also served on global leadership teams focused on mentoring and developing female leaders. Dr. Mattoon served as the Vice President for Product Development at Cell Signaling Technologies, a leading antibody provider, from July 2014 to February 2018, after which she joined Quanterix.

What is Dawn R. Mattoon's net worth?: The estimated net worth of Dawn R. Mattoon is at least $433,293.00 as of April 1st, 2022. Dr. Mattoon owns 36,876 shares of Quanterix stock worth more than $433,293 as of November 23rd. This net worth approximation does not reflect any other assets that Dr. Mattoon may own. Learn More about Dawn R. Mattoon's net worth.
How do I contact Dawn R. Mattoon?: The corporate mailing address for Dr. Mattoon and other Quanterix executives is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. Quanterix can also be reached via phone at (617) 301-9400 and via email at [email protected]. Learn More on Dawn R. Mattoon's contact information.
Has Dawn R. Mattoon been buying or selling shares of Quanterix?: Dawn R. Mattoon has not been actively trading shares of Quanterix within the last three months. Most recently, Dawn Mattoon sold 261 shares of the business's stock in a transaction on Friday, April 1st. The shares were sold at an average price of $29.79, for a transaction totalling $7,775.19. Following the completion of the sale, the vice president now directly owns 36,876 shares of the company's stock, valued at $1,098,536.04. Learn More on Dawn R. Mattoon's trading history.
Who are Quanterix's active insiders?: Quanterix's insider roster includes Amol Chaubal (CFO), Marijn Dekkers (Director), David Duffy (SVP), John Fry (General Counsel), E Hrusovsky (CEO), Dawn Mattoon (VP), and Mark Roskey (SVP). Learn More on Quanterix's active insiders.
Are insiders buying or selling shares of Quanterix?: During the last year, Quanterix insiders bought shares 1 times. They purchased a total of 47,000 shares worth more than $624,630.00. During the last year, insiders at the sold shares 2 times. They sold a total of 2,500 shares worth more than $60,025.00. The most recent insider tranaction occured on August, 20th when Director David R Walt bought 47,000 shares worth more than $624,630.00. Insiders at Quanterix own 6.9% of the company. Learn More about insider trades at Quanterix.
Information on this page was last updated on 8/20/2024.

Dawn R. Mattoon Insider Trading History at Quanterix

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2022	Sell	261	$29.79	$7,775.19	36,876
2/9/2022	Sell	318	$34.97	$11,120.46
2/2/2022	Sell	267	$31.46	$8,399.82
12/1/2021	Sell	353	$40.29	$14,222.37
11/5/2021	Sell	8,535	$57.28	$488,884.80
11/2/2021	Sell	333	$52.61	$17,519.13
8/3/2021	Sell	346	$53.79	$18,611.34
6/1/2021	Sell	243	$48.32	$11,741.76
5/3/2021	Sell	234	$57.86	$13,539.24
4/1/2021	Sell	215	$62.52	$13,441.80
2/1/2021	Sell	182	$68.26	$12,423.32
1/5/2021	Sell	170	$44.13	$7,502.10
12/1/2020	Sell	158	$43.75	$6,912.50	31,270
11/2/2020	Sell	159	$36.97	$5,878.23
9/1/2020	Sell	165	$34.91	$5,760.15
6/1/2020	Sell	162	$27.32	$4,425.84
5/1/2020	Sell	165	$25.44	$4,197.60
4/1/2020	Sell	97	$17.44	$1,691.68
3/13/2020	Sell	566	$16.04	$9,078.64
2/4/2020	Sell	137	$26.71	$3,659.27
1/2/2020	Sell	115	$23.18	$2,665.70
12/2/2019	Sell	115	$25.06	$2,881.90
8/1/2019	Sell	113	$31.62	$3,573.06
7/1/2019	Sell	112	$34.64	$3,879.68
6/4/2019	Sell	113	$25.81	$2,916.53
5/13/2019	Sell	652	$20.02	$13,053.04
5/1/2019	Sell	65	$22.59	$1,468.35
4/2/2019	Sell	72	$23.27	$1,675.44
3/1/2019	Sell	75	$25.00	$1,875.00
2/26/2019	Sell	890	$23.72	$21,110.80

Dawn R. Mattoon Buying and Selling Activity at Quanterix

Quanterix Company Overview

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $11.75

$11.58

$12.12

50 Day Range

MA: $12.86

$11.02

$15.49

2 Week Range

Now: $11.75

$10.50

$29.70

Volume

256,544 shs

Average Volume

476,778 shs

Market Capitalization

$450.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.